Expect a bumper year for weight-loss drugs
In 2024 Novo Nordisk and Eli Lilly will battle for dominance. The market for drugs such as Wegovy and Mounjaro could be worth $77bn by 2030 | The World Ahead
Stay updated with breaking news from Natasha Loder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In 2024 Novo Nordisk and Eli Lilly will battle for dominance. The market for drugs such as Wegovy and Mounjaro could be worth $77bn by 2030 | The World Ahead
Our podcast on science and technology. This week, we explain why the Nobel prizes have an impact far beyond the lab | Podcasts
Our podcast on science and technology. This week, we take a trip to the Royal Society’s summer science exhibition | Podcasts
Our podcast on science and technology. This week, we examine why this mainstay of modern medicine is ailing, and meet the people trying to make it all better | Podcasts
The investment case for bolstering global systems for pandemic preparedness and response is clear. Yet, COVID-19 exposed gaping holes in our collective ability to respond to pandemic threats. And even after more than 6.9 million deaths from COVID-19 and trillions in economic losses, financing and policy arrangements for preparedness remain insufficient. Policymakers still need to reckon with the lessons learned during recent outbreaks to ensure stronger systems going forward.